Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial
Bengaluru: Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a dangerous type of…